Selank FAQ: what the research actually shows

Last updated 2026-07-30

What is selank and what is it supposed to do?

Selank is a synthetic peptide, a short chain of seven amino acids, built as an analog of tuftsin, a naturally occurring immunomodulator peptide fragment of IgG. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences developed it in the 1990s, aiming for something with tuftsin's calming properties but a longer half-life and no unwanted immune activation ^[1]. In practice, people take it for two overlapping reasons: as an anxiolytic (anxiety reducer) and as a mild nootropic (cognitive support, particularly under stress). The Russian pharmacological literature describes it as having "anxiolytic, antidepressant and nootropic activity" without the sedation or dependence risk associated with benzodiazepines ^[2]. It's sold in Russia as a prescription nasal spray under the brand name Selank, manufactured by Peptogen and studied for conditions ranging from generalized anxiety disorder to mixed anxiety-depressive disorder. Outside Russia, it circulates mostly as a research chemical, typically as injectable or intranasal solution, sold for research purposes only. That distinction matters a lot for anyone trying to figure out how seriously to take the claims.

How strong is the clinical evidence for selank, really?

Honestly: it's a mixed bag, and almost all of it is Russian-language. That's the single most important thing to understand before you read anything else about this peptide. The most cited human trial is a 2008 paper on generalized anxiety disorder published in Neuroscience and Behavioral Physiology, a Russian journal translated into English by Springer. It compared Selank nasal spray to placebo in patients with GAD and reported meaningful reductions in anxiety scores, describing the peptide as having "a marked anxiolytic effect comparable with that of the benzodiazepine tranquilizers but without their negative side effects" ^[3]. That's a real, peer-reviewed (by Russian standards) clinical trial, not internet folklore. But here's the catch. It was small, it wasn't registered on ClinicalTrials.gov, and it hasn't been independently replicated by a Western research group in an English-language, internationally indexed journal. PubMed lists selank studies going back to the mid-2000s, but the overwhelming majority originate from Russian institutions, often the same handful of labs (Institute of Molecular Genetics, Institute of Normal Physiology) that developed the compound in the first place. That's not automatically bad science. It does mean there's no independent confirmation, and no large multi-site randomized controlled trial of the kind the FDA would expect to see before approving a drug in the US. Animal studies are more numerous and more mechanistically detailed: rodent work on selank's effects on brain-derived neurotrophic factor (BDNF) expression, GABA and serotonin systems, and enzyme activity tied to enkephalin degradation ^[4]. These give a plausible biological story for why it might reduce anxiety. Plausible mechanism is not the same as proven clinical effect in humans, though, and readers should hold that line firmly. If you want the fuller picture including patient-reported experiences, the selank reviews page collects what people actually report, and selank success rate tries to put rough numbers on how often users report a noticeable effect.

Is selank approved by the FDA?

No. Selank has no FDA approval of any kind, not as a prescription drug, not as an over-the-counter supplement, and not as a dietary ingredient. It doesn't appear in the FDA's Orange Book of approved drug products, and it isn't marketed legally in the US as anything you can buy for human consumption ^[5]. In Russia, the situation is different: Selank is a registered medicine, available by prescription as a nasal spray, and it's gone through Russia's own regulatory process (overseen by Roszdravnadzor, the Russian health oversight agency). That's a real regulatory approval, but it operates under a different evidentiary standard than the FDA's, and it doesn't transfer. Approval in one country's system is not equivalent to approval in another's, and readers should treat "approved in Russia" as a fact about Russian regulation, not a stamp of Western clinical validation. In the US, selank exists in a research chemical gray zone. It's not scheduled as a controlled substance, but it's also not legal for sale as a drug or supplement for human use. Most US and EU vendors sell it labeled "for laboratory research use only, not for human consumption," which is a legal fiction that everyone involved understands but that keeps sellers on the right side of FDA enforcement for unapproved drugs ^[6].

Selank vs semax: what's the difference?

People conflate these two constantly because they came out of the same Russian research pipeline and get marketed to the same crowd, but they're chemically and functionally distinct peptides. Semax is a synthetic analog of ACTH (adrenocorticotropic hormone) fragment 4-10, developed by the same Institute of Molecular Genetics group, and it's studied mostly for cognitive enhancement, stroke recovery, and attention/focus in the Russian literature ^[7]. It's registered in Russia as a nasal spray for conditions including ischemic stroke and cognitive impairment. Selank, again, is a tuftsin analog, and its research focus sits more on anxiety and mood regulation, with cognitive benefits described as secondary or downstream of reduced anxiety (less anxious people tend to think more clearly). Some users report semax feels more stimulating and "activating," while selank feels calming without sedation. Neither of those descriptions comes from a rigorous head-to-head trial. They're just how the peptide community and some Russian case reports describe the subjective difference. If your main goal is a wired, focused feeling, semax is the one more people reach for. If it's anxiety, selank is the one with a GAD trial behind it, thin as that trial base is.

How is selank typically dosed and administered?

In the Russian clinical trials, Selank was administered intranasally, typically at doses in the range of 250 to 3000 micrograms per day, split across two or three administrations, with the GAD trial using a 3 mg/day regimen over the study period ^[3]. Outside clinical settings, in the peptide research community, people typically report intranasal doses somewhere between 250 and 900 micrograms per dose, once or twice a day, though there's no standardized human dosing guideline because there's no approved US product with an FDA-reviewed label to point to. Anyone quoting you a precise "optimal dose" is speaking from anecdote and Russian trial data, not an approved prescribing standard. Injectable (subcutaneous) use also shows up in forums and some vendor literature, but the clinical trial data is specifically about the intranasal spray formulation, so extrapolating to injection changes the pharmacokinetics in ways nobody has studied carefully in humans.

What does selank feel like, and how fast does it work?

Users and the Russian trial data both describe a fairly quick onset, often within 30 to 60 minutes of intranasal dosing, with effects that are described as calming rather than sedating. The 2008 GAD trial reported measurable anxiety symptom reduction using the Hamilton Anxiety Rating Scale within the first week of daily use, with continued improvement over the trial period ^[3]. Subjectively, people describe less rumination, an easier time initiating tasks, and a flatter response to normally stressful triggers, without the flat, foggy feeling some describe with benzodiazepines. That said, this is exactly the kind of self-reported, expectation-sensitive outcome that's hardest to trust without a solid placebo arm, and most of what's floating around online is individual report, not data. For a sense of what a realistic week-by-week pattern looks like based on both the trial data and user reports, the selank results timeline page walks through it in more detail, and selank before and after collects more of the qualitative side.

Is selank safe? What side effects are reported?

The Russian clinical literature and the animal toxicology work both describe selank as having a favorable safety profile compared to benzodiazepines, with no reported physical dependence, withdrawal syndrome, or significant sedation in the trials conducted ^{[2] [3]}. That's a genuinely notable finding if it holds up, because dependence is the main reason clinicians are cautious about long-term anxiolytic use. Reported side effects in the trials and case reports are mild: transient nasal irritation from the spray, mild drowsiness in a minority of users, occasional headache. No serious adverse events were reported in the published trial data. But "no serious adverse events reported in a small trial" is a much weaker safety claim than "extensively studied for safety in large populations," which is what you'd expect before trusting a compound at scale. There's no long-term safety data beyond a few months, no data on interactions with common medications like SSRIs or benzodiazepines, and no data in pregnant or breastfeeding populations, in children, or in people with significant comorbid conditions. Anyone with an existing psychiatric diagnosis or on other medication should talk to an actual prescriber before adding an unregulated peptide, not a forum thread. For a fuller weighing of the upsides against these gaps, selank pros and cons lays it out side by side.

How does selank work in the brain (mechanism)?

The proposed mechanism runs through several systems rather than one clean receptor story, which is typical for peptides like this. Animal studies suggest selank affects the GABAergic system (the brain's main inhibitory, calming neurotransmitter pathway), modulates serotonin turnover, and increases expression of brain-derived neurotrophic factor (BDNF), a protein involved in neuron growth and plasticity ^[4]. It's also been shown in rodent studies to inhibit enkephalin-degrading enzymes, which would prolong the activity of the body's own opioid-like peptides involved in mood regulation ^[8]. That's a biologically plausible, multi-system story, and it's consistent with an anxiolytic-without-sedation profile. It is, again, mostly rodent data plus a handful of small human trials measuring symptom scales, not human neuroimaging or receptor-binding studies that would nail down the mechanism definitively. Treat the mechanism explanation as a reasonable hypothesis, not settled pharmacology.

Can selank help with focus or ADHD-like symptoms?

Some of the Russian literature on selank touches on cognitive performance, generally framed as an indirect effect: reduce anxiety and rumination, and working memory or attention improves as a side effect of a calmer baseline state ^[2]. That's different from a direct stimulant-style focus effect. There's no clinical trial of selank specifically for ADHD, in Russia or anywhere else, and no regulatory body recognizes it as an ADHD treatment. People who want a more attention/focus-forward peptide from the same research lineage typically look at semax instead, which has more of its Russian trial history built around cognitive and neurological recovery contexts (post-stroke cognitive deficit, for instance) rather than anxiety ^[7]. If your primary complaint is attention and distractibility rather than anxious rumination, selank is probably not the better-matched compound based on what the literature actually studied.

Where does selank fall on legal status in the US and elsewhere?

In the US, selank isn't a scheduled controlled substance under the Controlled Substances Act, so possession isn't specifically criminalized the way, say, a Schedule II stimulant would be. But it also has no FDA approval for human use, and selling it as a drug or supplement for people to consume violates the Federal Food, Drug, and Cosmetic Act's provisions on unapproved new drugs ^{[5] [6]}. That's why virtually every legitimate seller markets it as "research use only," a label that technically restricts it to laboratory and non-human research contexts. In practice, a lot of buyers use it off-label for themselves, which sits in a legal gray zone: not explicitly illegal to possess, but not approved, tested, or quality-controlled the way an FDA drug is. In Russia, it's the opposite: a prescription medicine with its own regulatory file. In the EU, it has no marketing authorization from the European Medicines Agency, similar to the US situation. Nobody should assume that because it's sold on a website, it carries any regulatory blessing outside Russia.

Where should I actually buy selank, and does sourcing matter?

Sourcing matters more with peptides than with almost any other research chemical category, because peptide degradation, contamination, and mislabeling are common problems in an unregulated supply chain. A 2022 analysis of research peptide vendors found substantial batch-to-batch purity variation and, in some products, outright absence of the labeled peptide, though that analysis focused on a different set of peptides sold in the same gray market ^[9]. The practical takeaway: buy from a source that can show a certificate of analysis for the specific batch you're getting, not a generic PDF pulled from a website. Given the total absence of FDA oversight here, third-party testing is the only quality signal you actually have. Selank Co works with a provider-reviewed sourcing route and names the pharmacy partner that fulfills orders, rather than compounding or manufacturing anything itself. That's a meaningfully different model than an anonymous overseas peptide shop, and it's worth understanding that distinction before you buy anywhere. Whichever source you use, ask directly for batch-specific testing and don't accept vague reassurance in place of paperwork.

Is selank worth trying, given the evidence gaps?

That depends heavily on your risk tolerance and what alternative you're weighing it against. Compared to starting an SSRI or benzodiazepine, selank has a much thinner human evidence base, no FDA oversight, and no long-term safety data, but it also has a reported side effect profile that's mild and a mechanism that doesn't look like it carries dependence risk. Compared to doing nothing, or to established first-line anxiety treatments like CBT or SSRIs which do have large, replicated randomized trial data behind them, selank is a much bigger evidence leap of faith. The honest framing is: this is an unapproved compound with promising but unreplicated foreign clinical trial data, not a validated anxiety treatment with a body of Western literature behind it. For a structured comparison of the upsides and downsides, is selank worth it walks through the decision in more depth, weighing the Russian trial signal against the regulatory and safety-data gaps discussed here.

Frequently asked questions

Is selank the same thing as semax?

No. Selank is a tuftsin analog studied mainly for anxiety; semax is an ACTH fragment analog studied mainly for cognitive and neurological recovery, including stroke. Both came from the same Russian research institute and get marketed to similar buyers, but they're different molecules with different study focuses and reported effects.

Does selank show up on a drug test?

There's no published data on selank triggering standard drug tests, and it isn't a controlled substance in the US, so it isn't part of routine workplace or clinical drug panels. That's an absence-of-data situation, not a confirmed clean bill, since nobody has specifically validated this against common testing panels.

Is selank legal to buy and possess in the US?

It's not a scheduled controlled substance, so simple possession isn't specifically criminalized, but it has no FDA approval for human consumption. Most US vendors sell it labeled for research use only, which is the legal workaround sellers use, not a certification that using it yourself is authorized.

How long does a bottle or vial of selank typically last?

That depends entirely on concentration and dosing frequency, which vary widely across unregulated vendor products, so there's no standardized answer. Users typically report a single vial lasting somewhere from one to a few weeks at commonly reported intranasal doses, but nobody should treat that as a clinical dosing guideline.

Has selank been tested in a large randomized controlled trial?

The most cited human trial, published in 2008 in Neuroscience and Behavioral Physiology, tested selank nasal spray against placebo in generalized anxiety disorder patients and reported an anxiolytic effect. It was a small Russian trial, not registered on ClinicalTrials.gov, and it hasn't been replicated by an independent Western research group since.

Can I take selank with an SSRI or benzodiazepine?

There's no published interaction data for selank combined with SSRIs, benzodiazepines, or other psychiatric medications. Given that gap, anyone on existing anxiety or depression medication should talk to their prescriber before adding selank rather than guessing based on forum reports.

Why is so much of the selank research in Russian?

Selank was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1990s, and it's registered as a prescription medicine in Russia. Its research and clinical trial history stayed largely within Russian institutions and Russian-language journals, most of which have never been replicated by Western labs.

Does Russian regulatory approval mean selank is FDA approved?

No. Selank's registration as a medicine in Russia, overseen by Roszdravnadzor, is a separate regulatory system with its own evidentiary standards. It has no bearing on FDA status in the US, where selank has no approval of any kind and isn't legally marketed for human use.

What's the difference between selank nasal spray and injectable selank?

The Russian clinical trials used an intranasal spray formulation, which is what the published dosing and safety data actually describes. Injectable versions circulate in the research chemical market, but their absorption and effects haven't been separately studied, so trial data doesn't cleanly transfer to that route.

How quickly does selank start working?

Users and the 2008 GAD trial both describe onset within roughly 30 to 60 minutes for a felt calming effect, with measurable symptom score improvement appearing within the first week of daily use in the trial data. Individual response varies widely and much of the fast-onset report is subjective rather than lab-measured.

Is selank addictive or does it cause withdrawal?

The published trial and animal data report no evidence of physical dependence or withdrawal syndrome with selank, unlike benzodiazepines. That said, the safety data comes from small, short-duration studies, so long-term dependence risk over months or years of use hasn't been rigorously tested.

Should I trust anecdotal reviews of selank over the clinical trial data?

Neither should be trusted alone. The clinical trial data, while real and peer-reviewed by Russian standards, is small and unreplicated; anecdotal reviews are shaped by expectation and lack any placebo control. The honest approach weighs both while being explicit about how thin each one is.

Sources

1. PubMed, Kolomin et al., peptide research overview: Selank is a synthetic peptide analog of tuftsin developed for anxiolytic and nootropic activity
2. PubMed, Neuroscience and Behavioral Physiology, selank pharmacology review: Selank is described as having anxiolytic, antidepressant and nootropic activity without dependence risk
3. PubMed, 2008 selank generalized anxiety disorder trial, Neuroscience and Behavioral Physiology: Selank nasal spray trial in GAD patients reporting anxiolytic effect comparable to benzodiazepines without negative side effects, dosing details
4. PubMed, selank and BDNF/GABA mechanism study: Selank affects GABAergic and serotonergic systems and increases BDNF expression in animal studies
5. FDA, Orange Book: Approved Drug Products: Selank does not appear among FDA-approved drug products
6. FDA, Federal Food, Drug, and Cosmetic Act unapproved drugs guidance: Selling an unapproved drug for human use violates FDA unapproved new drug provisions
7. PubMed, semax ACTH fragment analog studies: Semax is an ACTH(4-10) fragment analog studied for cognitive and stroke recovery outcomes, distinguishing it from selank
8. PubMed, selank enkephalin-degrading enzyme inhibition study: Selank inhibits enkephalin-degrading enzymes in animal studies, prolonging endogenous opioid peptide activity
9. NCBI/PMC, peptide product quality and contamination analysis: Research peptide products sold online show batch-to-batch purity variation and quality control gaps